Leading research and innovation in gene and cell therapy
Mary Ann Liebert Inc. is the proud publisher of groundbreaking, peer-reviewed journals including Human Gene Therapy and The CRISPR Journal, providing all-inclusive coverage of the research, developments, and novel technologies that are driving today's explosion of gene therapy advances. Its flagship trade magazine, GEN (Genetic Engineering & Biotechnology News), was the first in its field and remains the key driver in the growth of the industry, paving the way for the development of new technologies and applications, and investment and career opportunities.
Brands: Human Gene Therapy, The CRISPR Journal, Genetic Engineering & Biotechnology News